The research within the PCDIAB consortium focuses on the development of a portable bihormonal (insulin and glucagon) artificial pancreas.
To this end the PCDIAB consortium will:
- Include automated closed loop glycaemic control
- Incorporate exercise detection in the control algorithm
- Develop a glucagon formulation
- Perform a multinational controlled trial to compare the bihormonal artificial pancreas to with standard insulin therapy in daily life